Observationa Study is a Prospective and Multi-institutional Observational Study.

NCT06952855 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5536

Last updated 2025-05-13

No results posted yet for this study

Summary

This observational study is a prospective, multi-institutional non intervention study to examine the prescription patterns, corresponding treatment effects and safety in routine clinical practice for patients prescribed for the treatment of gastroesophageal reflux disease.

Conditions

  • Erosive Reflux Disease
  • Heartburn
  • Acid Regurgitation

Sponsors & Collaborators

  • Jeil Pharmaceutical Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-04-23
Completion
2025-04-23

Countries

  • South Korea

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06952855 on ClinicalTrials.gov